University of California Appeals CRISPR Patent Decision

Sharon Begley, 13 April 2017, STAT News,

UC-Berkeley has filed an appeal with the federal Court of Appeals.  UC-Berkeley was joined in its appeal by the University of Vienna and Emmanuelle Charpentier.  Previously, the US Patent office had ruled that UC-Berkeley’s and the Broad Institute’s patents did not interfere, leaving them both able to pursue unique patents.  In this appeal, UC-Berkeley hopes to establish that the teams led by Doudna and Charpentier were the first to engineer CRISPR/Cas9 in all cell types.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply